Physician profile
Blair S Macphail
NPI 1760440127
$9,117.98
in general payments reported to CMS, 2019-2025
41 companies · $1,257 in 2025
The $1,257 reported for 2025 was more than what 75% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,619 · 2020: $154 · 2021: $310 · 2022: $1,158 · 2023: $1,111 · 2024: $1,508 · 2025: $1,257.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,876.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,876.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,489.27 | 2019-2025 | Eluvia, Watchman Flx, Emblem Mri S-Icd |
| Abiomed | $1,396.27 | 2019-2025 | Impella |
| Novartis Pharmaceuticals Corporation | $1,051.99 | 2019-2025 | |
| Philips North America LLC | $654.83 | 2019-2025 | Mcot |
| Penumbra, INC. | $398.10 | 2020-2024 | Indigo System, Penumbra System |
| Pfizer INC. | $370.06 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $342.60 | 2019-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $307.02 | 2019-2022 | |
| Medtronic, INC. | $292.73 | 2021-2025 | Symplicity G3, Abre, Spiderfx |
| E.R. Squibb & Sons, L.L.C. | $257.17 | 2022-2025 | Breyanzi, Camzyos, Eliquis |
| Abbott Laboratories | $142.57 | 2022-2025 | Cardiomems, Jeti Peripheral Catheter, Esprit |
| Shockwave Medical, INC | $139.78 | 2021-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Sanofi-Aventis U.S. LLC | $110.27 | 2019 | |
| Amgen INC. | $105.08 | 2019-2024 | Repatha |
| Merck Sharp & Dohme LLC | $96.14 | 2022-2023 | Verquvo |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endologix LLC | $86.62 | 2019 | |
| Angiodynamics, INC. | $81.21 | 2024 | Auryon Laser System 100-120 Vac |
| Cardiovascular Systems INC. | $79.90 | 2020-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $71.23 | 2022-2023 | Jardiance |
| W. L. Gore & Associates, INC. | $59.98 | 2024-2025 | Gore Viabahn Vbx Balloon Expandable Endo, Excluder Conformable Aaa Endoprosthesis With Active Control |
| Lexicon Pharmaceuticals, INC. | $58.20 | 2023-2024 | Inpefa |
| Teleflex LLC | $56.77 | 2023-2025 | Vascband, Guideliner |
| Kiniksa Pharmaceuticals International, Plc | $49.62 | 2024 | Arcalyst |
| Imperative Care, INC | $45.77 | 2025 | Prodigy Catheter, Symphony Catheter |
| Medtronic Vascular, INC. | $39.53 | 2019 | |
| Scpharmaceuticals INC. | $34.36 | 2024-2025 | |
| Veryan Medical Incorporated | $33.94 | 2024-2025 | Biomimics 3d Vascular Stent System |
| Cardiva Medical, INC. | $29.42 | 2021-2022 | |
| Acist Medical Systems, INC. | $26.88 | 2022 | |
| Gilead Sciences, INC. | $26.51 | 2019 | |
| Bard Peripheral Vascular, INC. | $25.26 | 2025 | Trek |
| Irhythm Technologies, INC. | $22.58 | 2024 | Zio Monitor, Zio Xt Patch |
| Elutia, INC. | $20.72 | 2022 | |
| Argon Medical Devices, INC. | $20.22 | 2023 | Ivcf |
| Terumo Medical Corporation | $17.31 | 2022 | |
| Cathworks, INC. | $14.64 | 2025 | Ffrangio |
| Cook Medical LLC | $14.21 | 2025 | Resonance |
| Cordis US Corp. | $13.85 | 2025 | Mynxgrip |
| Biotronik INC. | $13.21 | 2024 | Orsiro Mission, Pk Papyrus |
| Livanova USA, INC. | $11.28 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $10.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Blair Macphail listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.